Answers are grounded in this paper and cite their sources.
IntroductIontwo different propofol formulation agents (2, 6-diisopropylphenol) have frequently been used in general anesthesia and sedation.they have the same chemical structure, pharmacokinetics and pharmacodynamic characteristics, clinical use, and administration methods (1).Propofol 1% contains 10% soybean oil, 2.25% glycerol, and 1.2% purified egg phosphatide (2). the lipid carriers in propofol are 10% long-chain fatty acids (Lct).However, the lipid carriers in Propofol-Lipuro include 5% medium-chain fatty acids (Mcts)/5% Lcts and 2.5% glycerol (3).Propofol emulsions strongly support bacterial growth and cause endotoxin contamination (4, 5).Some of the emulsions currently used include 0.005% ethylenediaminetetraacetic acid (EdtA), which delays bacterial growth (6).the concentration of EdtA in the emulsions was shown to have antibacterial characteristics with a delayed increase in millimetric colony-forming units (cFus).clinical studies have shown that the aqueous phase of free propofol in propofol injections was correlated with the degree of pain (7).Propofol-Lipuro was developed to decrease injection pain with the inclusion of Mcts.
No takes yet. Share an insight, caveat, or question.
Ertaş et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: